Nab-PH+Pyrrolitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nab-PH+Pyrrolitinib, covering 2025-03-07 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC [Phase 2]